Century Therapeutics, Inc.
NASDAQ:IPSC · NASDAQ Global Select
+$0.01 today
Vol 0.79M · Avg 1.16M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+268.74%
Period High
$2.94
Period Low
$0.46
Latest
$2.18
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Karyopharm Therapeutics Inc.
NASDAQ:KPTI
$215.30M
Equillium, Inc.
NASDAQ:EQ
$99.82M
OS Therapies Incorporated
AMEX:OSTX
$75.71M
Cue Biopharma, Inc.
NASDAQ:CUE
$64.46M
Coeptis Therapeutics, Inc.
COEP
$57.63M
Outlook Therapeutics, Inc.
NASDAQ:OTLK
$50.19M
Telomir Pharmaceuticals, Inc. Common Stock
TELO
$43.32M
Genenta Science S.p.A.
GNTA
$35.80M
Senti Biosciences, Inc.
SNTI
$25.24M
Medicus Pharma Ltd. Common Stock
MDCX
$7.44M
What is the latest IPSC filing?
The latest filing shown is 4 dated Jun 12, 2026.
How many recent filings does IPSC have?
Intrinsic Alpha currently shows 20 recent filings for IPSC.
Explore More
Continue the stock analysis
Jump to another research area for this company.